Dr. Daniel Dermendjian, MD

  • Los Angeles, CA
  • Pain medicine (anesthesiology) physician
NPI1598262131
Medicare services, 2024
88
Medicare patients, 2024
53
Part D claims, 2024
32
Industry payments
$2,669
Affiliated sites
1
Practice address
2525 N Catalina St, Los Angeles, CA 90027
Practice phone
Call (818) 791-1398
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Tarzana Ambulatory Surgical Institute

Los Angeles, California

See all 3 affiliations

Find Dr. Dermendjian's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Daniel Dermendjian is a pain medicine (anesthesiology) physician in Los Angeles, California

Dr. Dermendjian practices at Tarzana Ambulatory Surgical Institute in Los Angeles, California.

Dr. Dermendjian's NPI, 1598262131, was assigned on April 10, 2018. Dr. Dermendjian graduated from Ross University School of Medicine in 2013. Dr. Dermendjian holds California license 176809.

NPI and contact details
NPI enumeration date
April 10, 2018
NPI status
Active
Practice phone
(818) 791-1398
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
35
Medical school graduation
2013

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data

Dr. Daniel Dermendjian practices at Tarzana Ambulatory Surgical Institute in Los Angeles, California

Dr. Dermendjian's primary practice is Tarzana Ambulatory Surgical Institute, at 2525 N Catalina St, Los Angeles, CA 90027 in Los Angeles County. The practice phone is (818) 791-1398.

  • Tarzana Ambulatory Surgical Institute
    2525 N Catalina St, Los Angeles, CA 90027 · Los Angeles CountyPhone(818) 791-1398

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Daniel Dermendjian is affiliated with 2 sites of care and 1 medical group

Dr. Dermendjian's primary practice is Tarzana Ambulatory Surgical Institute in Los Angeles, California. The medical group on file is Superclinic Professionals Medical Corp. Dmand AI also links Dr. Dermendjian to 1 more physician office, named with a free account.

See all 3 affiliations for Dr. Dermendjian

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Daniel Dermendjian's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dermendjian practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Tarzana Ambulatory Surgical InstituteAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Dermendjian practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Daniel Dermendjian is one of 492 pain medicine (anesthesiology) physicians in California

Pain medicine is Dr. Dermendjian's primary specialty in the NPI Registry, under taxonomy code 207LP2900X. Dr. Dermendjian is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Dermendjian's licenses on file in 3 states: California, Illinois and Ohio.

Specialties and state licenses

  • Pain medicine (anesthesiology), CaliforniaPrimaryLicense 176809 · 2022 to 2026 · taxonomy 207LP2900X
  • Illinois license2022 to 2026
  • Ohio license2019 to 2022

Pain medicine (anesthesiology) physicians near Dr. Dermendjian

Counts of pain medicine (anesthesiology) physicians with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Daniel Dermendjian billed Medicare for 88 services in 2024

CMS data shows 88 Medicare services from Dr. Dermendjian across 2 procedure codes in 2024, all of them office visits, for 53 Medicare patients. Medicare paid $6,853 for them. Every service was in an office.

Medicare services, 202488
Medicare patients53
Paid by Medicare$6,853
Procedure codes2

Dr. Dermendjian compared with the California median for pain medicine (anesthesiology) physicians, 2024

  • Dr. Dermendjian
  • California median
Medicare services
88vs 57485% below
Medicare patients
53vs 18571% below
Part D claims
13vs 25195% below

Medians across 451 pain medicine (anesthesiology) physicians in California with Dmand AI profiles that report each measure.

Dr. Dermendjian's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Dermendjian

Need commercial claims for Dr. Dermendjian?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Dermendjian and other pain medicine (anesthesiology) physicians in California.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Daniel Dermendjian treated 53 Medicare patients in 2024, average age 75

CMS counts 53 Medicare patients who saw Dr. Dermendjian in 2024. The largest group is 75 to 84, with 22 patients. 75% of them have arthritis, and 75% have high blood pressure. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dermendjian's median patient age at 43, with 78% women.

Medicare patients, 202453
Average age75
Average risk score1.76

Dr. Dermendjian's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Dermendjian's Medicare patients by sex, 2024

  • Women3770%
  • Men1630%

Chronic conditions among Dr. Dermendjian's Medicare patients, 2024

  1. Arthritis75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Tobacco use75%
  5. Diabetes62%
  6. Cancer51%
  7. Chronic kidney disease43%
  8. Anxiety32%

Share of Medicare patients with each condition. A patient can have several.

Dr. Dermendjian's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 43

Patient panel by sex, all payers

  • Women78%
  • Men21%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Daniel Dermendjian wrote 32 Medicare Part D claims in 2024

In 2024, Dr. Dermendjian wrote 32 Medicare Part D claims for 17 patients. 100% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $286 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

Part D claims, 202432
Drugs named by CMS1
Total drug cost$286
Part D patients17

Dr. Dermendjian's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Dermendjian's Part D claims, 2024

  • Opioids56%18 of 32 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 122024: 138%

Drugs named by CMS: 1 in 2024, 1 in 2023.

See all prescribing by Dr. Dermendjian

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

For MedTech and pharma teams

Find pain medicine (anesthesiology) physicians like Dr. Dermendjian by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Daniel Dermendjian received $2,669 in industry payments in 2022

CMS Open Payments shows 3 general payments to Dr. Dermendjian from 2 drug and device companies in 2022. Grants make up the largest share, 94% of the total. Medtronic, Inc. paid the most, $2,500.

General payments to Dr. Dermendjian by kind, 2022 to 2022

$2.7Kin total
  • Grants$2,50094%
  • Food and beverage$1696%

Companies that paid Dr. Dermendjian the most, 2022 to 2022

Share is of all general payments to this clinician.

See all payments to Dr. Dermendjian

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Daniel Dermendjian graduated from Ross University School of Medicine

Dr. Dermendjian graduated from Ross University School of Medicine in 2013.

  1. Medical schoolRoss University School of Medicine
  2. Board certified in anesthesiologyAmerican Board of Anesthesiology

Source: Dmand AI Professional Profile Data

Dr. Daniel Dermendjian accepts plans from 1 insurance carrier

Dr. Dermendjian is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.

  • CMS Medicare

Source: Dmand AI Insurance Network Data

Sources for Dr. Daniel Dermendjian's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Daniel Dermendjian

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Daniel Dermendjian's NPI number?

Dr. Daniel Dermendjian's NPI number is 1598262131. It was assigned on April 10, 2018, and it is active in the NPI Registry.

What kind of doctor is Dr. Daniel Dermendjian?

Dr. Daniel Dermendjian is a pain medicine (anesthesiology) physician in Los Angeles, California. The primary specialty in the NPI Registry is Pain Medicine (Anesthesiology) Physician (taxonomy code 207LP2900X).

Where does Dr. Daniel Dermendjian practice?

Dr. Dermendjian practices at 2525 N Catalina St, Los Angeles, CA 90027. Dr. Dermendjian's primary practice is Tarzana Ambulatory Surgical Institute in Los Angeles, California. Dmand AI also links Dr. Dermendjian to 1 physician office.

What is Dr. Daniel Dermendjian's office phone number?

The practice phone on file for Dr. Dermendjian is (818) 791-1398.

What is Dr. Daniel Dermendjian's medical license number?

Dr. Dermendjian holds California license 176809, one of the licenses on file in 3 states.

Which states has Dr. Daniel Dermendjian been licensed in?

Dmand AI has state licenses on file for Dr. Dermendjian in California (2022 to 2026), Illinois (2022 to 2026) and Ohio (2019 to 2022).

What medical group is Dr. Daniel Dermendjian part of?

Dr. Dermendjian is linked to Superclinic Professionals Medical Corp.

Does Dr. Daniel Dermendjian accept Medicare?

Yes. CMS data shows Dr. Dermendjian billed Medicare for 88 services in 2024.

How many Medicare patients does Dr. Daniel Dermendjian see?

CMS counts 53 Medicare patients who saw Dr. Dermendjian in 2024, with an average age of 75.

Is Dr. Daniel Dermendjian board certified?

Yes. Dr. Dermendjian is board certified in anesthesiology by the American Board of Anesthesiology.

Show 6 more questionsShow fewer questions

What services does Dr. Daniel Dermendjian bill to Medicare?

In 2024, Dr. Dermendjian's most billed Medicare services were office visit, established patient (99213) and office visit, new patient (99203).

Where did Dr. Daniel Dermendjian go to medical school?

Dr. Dermendjian graduated from Ross University School of Medicine in 2013.

What drugs does Dr. Daniel Dermendjian prescribe most?

In 2024 Medicare Part D data, Dr. Dermendjian's most prescribed drugs by claims were Tramadol HCl.

Has Dr. Daniel Dermendjian received payments from drug or device companies?

CMS Open Payments shows $2,669 in general payments to Dr. Dermendjian from 2 companies from 2022 to 2022. The largest total came from Medtronic, Inc.

How long has Dr. Daniel Dermendjian been practicing?

Dr. Dermendjian graduated from medical school in 2013, 13 years ago.

What insurance does Dr. Daniel Dermendjian accept?

Dr. Dermendjian is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.

Selling to pain medicine practices?

See pain medicine (anesthesiology) physicians in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)